CytRx (CYTR) Secures Key European Patent for Arimoclomol

September 10, 2009 8:47 AM EDT Send to a Friend
CytRx Corporation (NASDAQ: CYTR) announced that it has been granted a key patent by the European Patent Office ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login